Valeda Treatment for Dry Macular Degeneration: A New Non-Invasive Option
- Ms Yasmine Abdalla

- Mar 21
- 3 min read
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in the UK, particularly affecting people over the age of 60. While effective treatments exist for wet AMD, options for dry AMD have traditionally been limited.
One of the most exciting recent developments is Valeda photobiomodulation (PBM) — a non-invasive light therapy for dry AMD designed to support retinal health and help preserve vision.

What is Photobiomodulation?
Photobiomodulation (PBM) is an advanced medical treatment that uses low-level light therapy to stimulate retinal cells. It is specifically designed for patients with early to intermediate dry age-related macular degeneration.
Unlike injections or surgery, Valeda treatment is:
Non-invasive
Painless
Performed in clinic
Quick, with no recovery time
This makes it an attractive option for patients looking for dry AMD treatment in the UK without injections.
How Does the Valeda Treatment Work?
Valeda uses a process called photobiomodulation, which targets the mitochondria — the energy-producing structures within retinal cells.The treatment delivers three specific wavelengths of light (yellow, red and near-infrared), each penetrating different layers of the retina.
This helps to:
Improve cellular energy production
Enhance retinal function
Reduce inflammation
Reduce oxidative stress
These mechanisms are important because they directly target the underlying processes involved in dry macular degeneration.
Who is Suitable for Valeda Treatment?
Valeda is most effective for patients with:
Early to intermediate dry AMD
Good central vision
No active wet AMD
Early diagnosis is key. The treatment is designed to slow progression and improve retinal function before significant vision loss occurs. Your specialist will carry out a detailed retinal assessment, including imaging, to determine whether Valeda treatment is suitable for you.
What Does the Treatment Involve?
A typical Valeda treatment course consists of:
9 sessions over 3 to 5 weeks
Each session lasting only a few minutes
Treatment of one or both eyes
There is no downtime, and patients can return to normal activities immediately after each session.
What Are the Benefits of Valeda?
Clinical studies have shown that Valeda photobiomodulation can:
Improve visual acuity (vision clarity)
Improve contrast sensitivity
Reduce drusen (retinal deposits associated with AMD)
Slow the progression of dry AMD
For many patients, this represents a significant step forward in the management of a condition that previously had very limited treatment options.
Valeda vs Other AMD Treatments
Traditional treatment options for AMD depend on the type:
Wet AMD → treated with injections into the eye
Dry AMD → historically monitored with lifestyle advice
Valeda offers something different:
A non-invasive treatment for dry AMD
No injections or surgery
Targets the disease at a cellular level
Can be repeated over time
This makes it an important new option for patients looking for early intervention in macular degeneration.
Is Valeda Available in the UK?
Yes — Valeda treatment is now available in selected specialist clinics in the UK, including EyePros. As awareness grows, more patients are seeking Valeda treatment for macular degeneration in the UK, particularly those who have been told previously that no treatment was available for dry AMD.
A New Era in Dry AMD Treatment
For many years, dry macular degeneration has been a condition with limited treatment options.
Valeda photobiomodulation represents a shift towards proactive, non-invasive care, aiming to preserve vision and improve retinal health before irreversible damage occurs.
Book a Consultation
If you have been diagnosed with dry AMD or are concerned about changes in your vision, we recommend a specialist assessment. Your consultant ophthalmologist can determine whether Valeda treatment for macular degeneration is suitable for you and discuss the best options for your eye health.




Comments